Donata Verdelli
University of Milan(IT)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(IT)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Glycosylation and Glycoproteins Research, Protein Degradation and Inhibitors, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect(2009)143 cited
- → Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma(2005)130 cited
- → Molecular Classification of Multiple Myeloma: A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations(2005)116 cited
- → Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease(2006)66 cited
- → Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma(2007)66 cited
- → Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses(2004)49 cited
- → The oral protein-kinase Cβinhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines(2008)35 cited
- → Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma(2007)20 cited
- → Molecular targeting of the PKC‐β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression(2008)20 cited
- Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.(2005)